Medasense Biometrics LTD Revenue and Competitors

Medasense (www.medasense.com) is enabling clinicians to personalize pain management, optimize treatment, avoid overmedication and enhance patient outcomes with an innovative noninvasive sensor platform and AI technology. Medasense's flagship NOL® monitoring system (PMD-200™) harnesses AI and proprietary sensor technology to monitor and quantify the patient's physiological response to painful stimuli in operating rooms and critical care settings, where patients are unable to communicate. Clinical studies have demonstrated its impact on patient safety and outcomes – including reduced postoperative pain – as well as cost savings. The PMD-200™ enables connectivity with Philips patient monitors. It is distributed in Europe exclusively by Medtronic, and is commercially available in Canada, Australia, South Africa, Israel and select Latin American countries. The PMD-200™ is not commercially available in the U.S.